Online citations, reference lists, and bibliographies.

Metabolic Tumour Volume As A Prognostic Factor For Oral Cavity Squamous Cell Carcinoma Treated With Primary Surgery

Han Zhang, Hadi Seikaly, Jonathan T. Abele, Dean T. Jeffery, Jeffrey Richard Harris, Daniel A. O’Connell
Published 2014 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
BackgroundMetabolic tumour volume (MTV) obtained from pre-treatment 18 F-fluorodeoxydeglucose positron emission tomography with computed tomography (PET-CT) has been validated as an independent predictive factor of outcomes in head and neck cancer patients (HNC) treated with primary chemoradiotherapy (CRT). However its role in patients treated with primary surgery has not yet been studied.ObjectiveTo evaluate the prognostic value of MTV in patients treated with primary surgery for oral cavity squamous cell carcinoma (OCSCC).MethodDemographic and survival data was obtained from patients diagnosed with OCSCC from 2008-2012 in Alberta, Canada. All patients included in the study had PET-CT scan before curative surgical resection. MTV and maximum standardized uptake value (SUVmax) value was delineated from pre-treatment PET-CT scans using Segami Oasis software (Columbus, OH). MTV and SUVmax were divided into intertertile thirds before statistical analysis to allow for in-group comparison of survival.ResultsA total of 80 patients were analyzed using SPSS ver. 20.0 (SPSS Inc, Chicago, IL). Five-year overall, and disease-free survival using Kaplan-Meier curves were 70% and 73% respectively. When the combined SUVmax (tumour primary and locoregional metastasis) was evaluated, it failed to predict overall (HR = 1.0, p = 0.99) or disease-free survival (HR = 1.0, p = 0.227).Conversely an increase in MTV of 17.5 mL (difference between the highest and lowest MTV tertile) was associated with a 12.4 fold increase in risk of disease recurrence (p < 0.001) and an 11.2 fold increase in the risk of death (p < 0.05).ConclusionsThis study shows that MTV is an independent adverse prognostic factor for death and disease recurrence in OCSCC treated with primary surgery.
This paper references
Available at: http://www.cancer.ca/ Canadawide/About%20cancer/Cancer%20statistics.aspx?sc_lang=en (accessed on
(2013)
10.1056/NEJMoa032646
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
Jay Scott Cooper (2004)
CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
ME Charlson (1987)
10.1007/s00259-010-1693-9
AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual (7th edition)
Vincenzo Cuccurullo (2010)
10.1002/hed.23172
Neck metastases in oropharyngeal cancer: Necessity and extent of bilateral treatment.
Peter T Dziegielewski (2013)
10.1016/j.ijrobp.2010.01.057
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.
James D Murphy (2011)
10.1007/s12149-012-0604-5
Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy
Paul B Romesser (2012)
10.1056/NEJMe1003607
Prognostic implications of HPV in oropharyngeal cancer.
Douglas R Lowy (2010)
Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
Peter T Dziegielewski (2012)
Cancer Available at: http://www.albertahealthservices. ca/2171.asp (accessed
Alberta Heath Services (2013)
Ajcc Cancer Staging Manual. 7th Ed. New
York Springer (2010)
10.1002/lary.20619
A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the head and neck.
Christine G Gourin (2009)
10.1093/jnci/78.4.785-f
European Organization for Research and Treatment of Cancer.
Hiromi Fukuda (2000)
Journal of Otolaryngology -Head and Neck Surgery
Zhang (2014)
10.1001/archoto.2012.1404
A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Gerry F. Funk (2012)
10.1016/j.ijrobp.2011.03.029
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.
Benjamin H Lok (2012)
10.1056/NEJMoa0912217
Human papillomavirus and survival of patients with oropharyngeal cancer.
K Kian Ang (2010)
10.1186/1916-0216-42-30
Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis
Han Zhang (2013)
10.1016/j.ijrobp.2010.10.053
Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Anna Strongin (2012)
10.1016/j.ijrobp.2011.10.023
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
Chad Tang (2012)
10.1016/0021-9681(87)90171-8
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
Mary E. Charlson (1987)
10.1097/00000421-198212000-00014
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Martin M. Oken (1982)
10.1007/s00259-013-2528-2
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer
Maria Picchio (2013)
Radiation Therapy Oncology Group 9501/Intergroup: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
JS Cooper (2004)
10.1016/j.otohns.2006.01.029
Epidemiology of head and neck cancer in the United States
Louise Davies (2006)
10.1007/s00432-009-0729-7
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma
Peng Xie (2009)
Canadian Cancer Society statistics
10.1016/j.ijrobp.2008.10.060
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
Trang H. La (2008)
10.1002/ijc.22851
Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis.
Camille C R Ragin (2007)
10.1056/NEJMoa032641
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
Jacques Bernier (2004)
10.1200/JCO.2008.19.3300
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
Benjamin J. Moeller (2009)
10.1002/hed.22904
Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters.
Seung Hwan Moon (2013)
AJCC cancer staging handbook : from the AJCC cancer staging manual
Frederick L Greene (2002)
10.1002/jbm.a.31888
Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification.
Chad Tang (2009)



This paper is referenced by
10.1002/hed.25337
Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging
John M Floberg (2018)
10.1001/jamaoto.2020.0014
Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
Gwenaelle Creff (2020)
10.1002/ijc.30479
Implantable chemotherapy‐loaded silk protein materials for neuroblastoma treatment
Jeannine M Coburn (2017)
10.1101/2020.04.20.050492
Involvement of I-BAR protein IRSp53 in tumor cell growth via extracellular microvesicle secretion
Hooi Ting Hu (2020)
10.1007/s00330-020-06982-8
Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma
Noriyuki Fujima (2020)
10.1016/S1470-2045(19)30177-9
Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review.
Volker Budach (2019)
10.1016/j.oraloncology.2016.03.013
Validation of metabolic tumor volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery.
Han Zhang (2016)
10.1002/hed.24388
Human papillomavirus-associated oropharyngeal squamous cell carcinoma and anogenital cancers in men: Epidemiologic evaluation of association.
Hani Z. Marzouki (2016)
10.1186/s40463-017-0185-3
Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets
Cameron D Lindsay (2017)
10.18632/oncotarget.14743
The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinoma
Xinzhe Dong (2017)
Semantic Scholar Logo Some data provided by SemanticScholar